Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMO.. The man behind the curtain will not miss this opportunity to PUMP the SP up this week. Cannabix goal was always to have a device to coincide with legalization. I believe we'll see a news release about manufacturer/testing which will push BLOZF to new highs. The stock options paid to the two consultants tell me the prototype is complete, so you may get your wish of seeing a device. IMO..Show us a picture and this stock explodes!!!
ATH by Friday!!!
I'm 100% sure Owlstone would love to have our 3D Partial Ovoidal FAIMS Electrode to use with their products. IMO...I think we may have figured out why Kal & Gang are so determined to take our shares.
It just keeps getting better.
http://patriot1tech.com/wp-content/uploads/2018/10/Patriot-One-Newsletter-Issue-10.pdf
The Wisconsin State Patrol is participating in pilot tests of the marijuana-equivalent of a hand-held analyzer for alcohol on someone's breath, known as a breathalyzer, said David Pabst, the agency's director of transportation safety. No such unit is available now for wide-scale use.
Quote from Breathtec monthly report.
IMO this is our next NR here at BLOZF before the 17th.
BLOZF gonna BLO!!!
The Company has identified a third party research and technology development provider in order to advance the speed of the Company’s FAIMS prototype device program. The Company has been working on a research agreement draft.
"The recent submission of a pre-submission package marked the initiation of the FDA process for Imagin's i/Blue Imaging System, and Chris' diverse background working with companies in the medical device, diagnostic, nutrition and pharmaceutical industries should prove to be a tremendous asset to our Board and to our shareholders as we move forward," added Dr. Atlas.
Canadian police forces hold off on ordering the only device approved to test saliva for THC
Thank you smileplease on Stockhouse for your DD.
BLOZF Gonna BLO!!!
https://theprovince.com/news/politics/canadian-police-forces-hold-off-on-ordering-the-only-device-approved-to-test-saliva-for-thc/wcm/1edb44be-f22b-4db5-8ac7-e4618277d547
GrowMax Resources Comments on BullRun’s Value-Destructing Scheme to Pocket $2.1M of Shareholder Money
Shareholders deserve better than BullRun’s flipflopping and back-of-the-napkin business plans,” said GrowMax CEO Stephen Keith.
BullRun’s dividend scheme reveals their true intentions: They want to get their hands on GrowMax’s cash.
I recently stayed at the Westgate and IMO I’m now very confident that PAT is right on track with its Q4/phase 4 technology timeline. From what I heard, the phase 4 pilot development to key clients in reference to “resorts & casinos”… with plural casinos being accurate and imminent. I will not second hand the information to you, but IMO I’m convinced that this product also has MULTIPLE applications yet to be publicly disclosed. It’s going to be a great Q4 and beyond!!
letter from GA today
Hello;
Have had a lot of people asking about sales and when they will be announced and so we have put out the attached news release to address this important subject.
Background on today’s news release:
1. I am encouraged by the contacts with leading cardiologists that see many special situations where the information the VMS+ provides would greatly enhance the ability to properly diagnose, treat and monitor patients. This is great because making cardiac care better is our mission.
2. In June MD Anderson sent us the first purchase order and we have been working with them to set an installation date, which has now been set for the week of August 13th. This a big deal as this is the number one cancer center in the world. They will need 1,000 machines to address their 1.7 million patients each year, so this is just the first one of many more.
3. We have 5 other leading centres in US, Europe and Canada who have made the decision to buy the VMS+ and are going through their process to issue a purchase order. It is a slow business as hospitals have complex procedures to be sure they only buy what they need. While it is nice to know they absolutely need the VMS+, it is still frustrating. We have the machines ready to be installed so just waiting on the PO.
4. These new centres will also need many VMS+ machines to address their patient population so these are the first of many.
4. We are working hard to adapt the VMS+ so we can offer a subscription model for hospitals so they can get started quickly and we can move away from the capital purchase model. This is the trend in medical imaging - to outsource analysis - to allow cardiologists to focus on patient care and treatment. This will be the topic of the next update news release next week.
Thanks for the support in the public market.
Please call me if you haven questions.
Regards,
George Adams, PhD, ICD.D
CEO
Ventripoint Diagnostics Ltd..
Cell: 519-803-6937
TSXV: VPT
Ventripoint Provides Corporate Update on Sales and Marketing
https://web.tmxmoney.com/article.php?newsid=8919099639627388&qm_symbol=VPT
What Breathtec didn't even make the top 6 Bullrun ventures??? Not even mentioned.
About BullRun Capital
BullRun Capital Inc. is a venture capital group specializing in identifying and incubating world changing technologies and commercial projects. Past and current projects include: Patriot One Technologies (PAT.V), Cannabix Technologies (C.BLO), and Micron Waste Technologies (C.MWM). Additionally, BullRun is privately developing First Responder Technologies Inc, to develop a quick acting pepper spray and antidote for law enforcement, Nash Pharmaceuticals Inc to develop anti-fibrosis medications, and Kushtown Kultivations Inc to build a cannabis cultivation facility in California. BullRun’s team is led by its Founder and Chairman Kulwant (Kal) Malhi, and Alfred Wong its President. Information on BullRun Capital is found at http://www.bullruncapital.ca/
Talk about the pot calling the kettle black...IMO
GrowMax Resources Corp. - Requisition of Shareholder Meeting by BullRun Capital Inc.
www.globenewswire.com/news-release/2018/07/06/1534327/0/en/GrowMax-Resources-Corp-Requisition-of-Shareholder-Meeting-by-BullRun-Capital-Inc.html
I have an opinion but it doesn't amount to S%*t. Two companies, one technology. And one company feels they don't need any more "assistance in research or development". It seems like a big deal to me, yet nobody's talking about it. Trying to get the board thinking...
I'll ask the question again. Why is Breathtec agreement with UF for research and development ending in 2 weeks? While Cannabix agreement is continuing, any thoughts??
Breathtec US has an agreement (“Agreement”) with the University of Florida (“UF”) whereby UF assists the Company with research and development that is extended annually. The current Agreement, a no-cost extension, is for the period April 16, 2018 to July 15, 2018 and unlike the previous agreements, it does not require the Company to make any payment to UF. For the period January 16, 2017 to January 15, 2018 the Company paid a total of US$55,608 or $71,820 at the Canadian dollar equivalent.
Question...Does the agreement between Breathtec & UF for research and development come to an end on 7/15/18? Has it been extended?
Breathtec US has an agreement (“Agreement”) with the University of Florida (“UF”) whereby UF assists the Company with research and development that is extended annually. The current Agreement, a no-cost extension, is for the period April 16, 2018 to July 15, 2018 and unlike the previous agreements, it does not require the Company to make any payment to UF. For the period January 16, 2017 to January 15, 2018 the Company paid a total of US$55,608 or $71,820 at the Canadian dollar equivalent.
https://datac.ca/new-police-curriculum-to-detect-drug-impaired-driving/
Concerns are rising over what will be done to prevent impaired drivers from operating vehicles while awaiting results from their fluid tests, which can take up to six months.
USE OF ION MOBILITY SPECTROMETERS BY THE CORRECTIONAL SERVICE OF CANADA
https://www.ourcommons.ca/content/Committee/421/SECU/Reports/RP9998633/421_SECU_Rpt25_PDF/421_SECU_Rpt25-e.pdf
How Mass Spectrometry Technology is Changing the Face of Clinical Research
Dr. Marilyn Huestis
http://www.selectscience.net/downloads/articles/8377_WP-65121-LC-MS-Clinical-Research-WP65121-EN.pdf
MD Anderson Cancer Center is the First Hospital in USA to Order the VMS+ Complete Heart Analysis System
http://www.ventripoint.com/md-anderson-orders-vms.html
NIDA's Dr. Marilyn Huestis discusses marijuana impact on driving
https://www.sanluisobispo.com/news/state/california/california-weed/article211270564.html
The New Era of Cannabis Testing
https://www.aacc.org/publications/cln/cln-stat/2018/march/15/the-new-era-of-cannabis-testing
From just 2 months ago. Do we expect Huestis to change her positive view about swabs in her upcoming presentations?
We are 3-6 months away from court certified device.
We believe we can be court certified within 9-12 months which hopefully will coincide with legalization in Canada.
Huestis is coming to CSCC in Ottawa June 5th.
Symposium: Hot Topics in Toxicology: The Opioid Crisis and Cannabis Legalization
Tuesday June 5, 0900-1200
THC: The Great Cannabis Experiment
Marilyn Huestis, Senior Fellow, Lambert Center for the Study of Medicinal Cannabis & Hemp
Learning Objectives:
At the end of this session participants will be able to:
Describe the endogenous cannabis system.
Describe the effect of cannabis on lateral control.
Describe the rapidity with which ?9-tetrahydrocannabinol leaves the blood after cannabis inhalation.
Explain the advantages and limitations of oral fluid testing for cannabis.
This session will cover the short and long-term effects of cannabis medicalization and commercialization. The presentation will focus on the effects of cannabis on driving and new data from the world’s most advanced driving simulator, and data from the Drug Recognition Examiner study of 302 cannabis only cases. The session will be of value to Clinical Chemists, Trainees, Pathologists and the general public.
Lobbying for patriot one detection by E2 Strategies, LLC
http://disclosures.house.gov/ld/ldxmlrelease/2018/RR/300959064.xml
https://projects.propublica.org/represent/lobbying/301017549
Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System using 2D Ultrasound
https://web.tmxmoney.com/article.php?newsid=5182164249301316&qm_symbol=VPT
How is BTHCF going to raise the amount of $$$ required to get their FAIMS device through testing to a finished sellable product ? IMO they get a partnership/buyout once Cannabix validates the device with their testing. What other options do they have? Its obviously going to take some deep pockets to continue on from here.
In 2016, they spun off Owlstone Medical to develop and commercialize FAIMS technology in medical diagnostic applications with $31.5 million in funding taken in so far.
So they say it has been completed 7 weeks ago. So now what? Any guess what comes next/when?
Vancouver, British Columbia, January 23, 2018 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report development of its “Beta 3.0” (Cannabix Marijuana Breathalyzer) prototype device based on its FAIMS- (field asymmetric waveform ion mobility spectrometry) has been proceeding at a robust pace and is now complete. This device is designed to operate both independently or coupled in tandem directly to a conventional Quadrupole Mass Spectrometer (MS) device used in forensic labs.
Very interesting...this was posted on Stockhouse
http://www.stockhouse.com/companies/bullboard?symbol=c.blo&postid=27680654
Meaning $2.08 BLOZF Friday the 7th
We're halted. Any guess on where this goes once lifted?
I am still confused on how BTHCF releases news of a completed POC hand held device that correlates to MS and the SP drops. I guess that why i'm not a day trader.
Any guess on how much $$$ it will cost to fund this device to commercialization?